speb/financial-data huggingface dataset:
ACGL cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -1839000000.00
ACGL cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -768000000.00
ACGL balance_sheet (annual, 2025-12-31) — Net Debt: 1736000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Net Debt: 1736000000.00
ACGL income_statement (annual, 2025-12-31) — Net Income: 4399000000.00
ACGL income_statement (quarterly, 2025-12-31) — Net Income: 1238000000.00
ACGL income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 4359000000.00
ACGL income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 1228000000.00
ACGL income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 4399000000.00
ACGL income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 1238000000.00
ACGL income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 4399000000.00
ACGL income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1238000000.00
ACGL income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 4399000000.00
ACGL income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1238000000.00
ACGL cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 4399000000.00
ACGL cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 1238000000.00
ACGL income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 4399000000.00
ACGL income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 1238000000.00
ACGL income_statement (annual, 2025-12-31) — Net Interest Income: -148000000.00
ACGL income_statement (quarterly, 2025-12-31) — Net Interest Income: -38000000.00
ACGL cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -4098000000.00
ACGL cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -517000000.00
ACGL income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -148000000.00
ACGL income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -38000000.00
ACGL cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -4000000.00
ACGL cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
ACGL cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 106000000.00
ACGL cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 111000000.00
ACGL cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -44000000.00
ACGL cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -11000000.00
ACGL income_statement (annual, 2025-12-31) — Net Policyholder Benefits And Claims: 9370000000.00
ACGL income_statement (quarterly, 2025-12-31) — Net Policyholder Benefits And Claims: 2280000000.00
ACGL balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 22984000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 22984000000.00
ACGL income_statement (annual, 2025-12-31) — Normalized Income: 4399000000.00
ACGL income_statement (quarterly, 2025-12-31) — Normalized Income: 1238000000.00
ACGL cash_flow (annual, 2025-12-31) — Operating Cash Flow: 6172000000.00
ACGL cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 1404000000.00
ACGL cash_flow (annual, 2025-12-31) — Operating Gains Losses: -899000000.00
ACGL cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -201000000.00
ACGL income_statement (annual, 2025-12-31) — Operating Revenue: 19294000000.00
ACGL income_statement (quarterly, 2025-12-31) — Operating Revenue: 4760000000.00
ACGL balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 359000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 359000000.00
ACGL balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 5000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 5000000.00
ACGL income_statement (annual, 2025-12-31) — Other Income Expense: 271000000.00
ACGL income_statement (quarterly, 2025-12-31) — Other Income Expense: 68000000.00
ACGL balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 615000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 615000000.00
ACGL income_statement (annual, 2025-12-31) — Other Operating Expenses: 1955000000.00
ACGL income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 384000000.00
ACGL balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 10550000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 10550000000.00
ACGL balance_sheet (annual, 2025-12-31) — Payables: 4597000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Payables: 4597000000.00
ACGL balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 4597000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 4597000000.00
ACGL income_statement (annual, 2025-12-31) — Policyholder Benefits Ceded: 3865000000.00
ACGL income_statement (quarterly, 2025-12-31) — Policyholder Benefits Ceded: 1039000000.00
ACGL income_statement (annual, 2025-12-31) — Policyholder Benefits Gross: 13235000000.00
ACGL income_statement (quarterly, 2025-12-31) — Policyholder Benefits Gross: 3319000000.00
ACGL balance_sheet (annual, 2025-12-31) — Preferred Shares Number: 830000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Preferred Shares Number: 830000.00
ACGL balance_sheet (annual, 2025-12-31) — Preferred Stock: 830000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 830000000.00
ACGL cash_flow (annual, 2025-12-31) — Preferred Stock Dividend Paid: -40000000.00
ACGL cash_flow (quarterly, 2025-12-31) — Preferred Stock Dividend Paid: -10000000.00
ACGL income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 40000000.00
ACGL income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 10000000.00
ACGL balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 830000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 830000000.00
ACGL balance_sheet (annual, 2025-12-31) — Prepaid Assets: 2659000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 2659000000.00
ACGL income_statement (annual, 2025-12-31) — Pretax Income: 4979000000.00
ACGL income_statement (quarterly, 2025-12-31) — Pretax Income: 1387000000.00
ACGL cash_flow (annual, 2025-12-31) — Purchase Of Investment: -40166000000.00
ACGL cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -8970000000.00
ACGL cash_flow (annual, 2025-12-31) — Purchase Of PPE: -44000000.00
ACGL cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -11000000.00
ACGL balance_sheet (annual, 2025-12-31) — Receivables: 17519000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Receivables: 17519000000.00
ACGL income_statement (annual, 2025-12-31) — Reconciled Depreciation: 193000000.00
ACGL income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 47000000.00
ACGL cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -1889000000.00
ACGL cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -798000000.00
ACGL balance_sheet (annual, 2025-12-31) — Retained Earnings: 27045000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 27045000000.00
ACGL cash_flow (annual, 2025-12-31) — Sale Of Business: 0.00
ACGL cash_flow (annual, 2025-12-31) — Sale Of Investment: 36068000000.00
ACGL cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 8453000000.00
ACGL balance_sheet (annual, 2025-12-31) — Share Issued: 599800000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Share Issued: 599800000.00
ACGL cash_flow (annual, 2025-12-31) — Stock Based Compensation: 148000000.00
ACGL cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 24000000.00
ACGL balance_sheet (annual, 2025-12-31) — Stockholders Equity: 24206000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 24206000000.00
ACGL balance_sheet (annual, 2025-12-31) — Tangible Book Value: 22154000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 22154000000.00
ACGL income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ACGL income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ACGL income_statement (annual, 2025-12-31) — Tax Provision: 760000000.00
ACGL income_statement (quarterly, 2025-12-31) — Tax Provision: 210000000.00
ACGL income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
ACGL income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
ACGL balance_sheet (annual, 2025-12-31) — Total Assets: 79241000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Total Assets: 79241000000.00
ACGL balance_sheet (annual, 2025-12-31) — Total Capitalization: 26935000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 26935000000.00
ACGL balance_sheet (annual, 2025-12-31) — Total Debt: 2729000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Total Debt: 2729000000.00
ACGL balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 24206000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 24206000000.00
ACGL income_statement (annual, 2025-12-31) — Total Expenses: 14315000000.00
ACGL income_statement (quarterly, 2025-12-31) — Total Expenses: 3373000000.00
ACGL balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 55035000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 55035000000.00
ACGL balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 240800000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 240800000.00
ACGL balance_sheet (annual, 2025-12-31) — Treasury Stock: 6410000000.00
ACGL balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 6410000000.00
ACGL income_statement (quarterly, 2026-03-31) — +Total Revenue: 4376000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 4997000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 18511000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 2831000000.00
ACGL income_statement (quarterly, 2026-03-31) — Amortization: 30000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 30000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 30000000.00
ACGL income_statement (quarterly, 2026-03-31) — Basic Average Shares: 353200000.00
ACGL income_statement (quarterly, 2026-03-31) — Basic EPS: 2.94
ACGL cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 2067000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -8000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Capital Stock: 831000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 914000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 12175000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -15000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -827000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -639000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 1188000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 419000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -378000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Change In Payable: 419000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 419000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Change In Receivables: -820000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 75000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -820000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Changes In Cash: -278000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Common Stock: 1000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -5000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 23358000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -800000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 30000000.00
ACGL income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 30000000.00
ACGL income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 359700000.00
ACGL income_statement (quarterly, 2026-03-31) — Diluted EPS: 2.88
ACGL income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1037000000.00
ACGL income_statement (quarterly, 2026-03-31) — EBIT: 1146000000.00
ACGL income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest Net Of Tax: 36000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -137000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -8000000.00
ACGL cash_flow (quarterly, 2026-03-31) — End Cash Position: 1781000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -827000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 1180000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 91000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -333000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1190000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 22000000.00
ACGL income_statement (quarterly, 2026-03-31) — Interest Expense: 37000000.00
ACGL income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 37000000.00
ACGL income_statement (quarterly, 2026-03-31) — Interest Income: 8000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 0.00
ACGL balance_sheet (quarterly, 2026-03-31) — Invested Capital: 26087000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -639000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 45987000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Investments In Other Ventures Under Equity Method: 7982000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 2729000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 2729000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 7982000000.00
ACGL income_statement (quarterly, 2026-03-31) — Loss Adjustment Expense: 2089000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -800000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Net Debt: 1815000000.00
ACGL income_statement (quarterly, 2026-03-31) — Net Income: 1047000000.00
ACGL income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1037000000.00
ACGL income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1047000000.00
ACGL income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1047000000.00
ACGL income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1047000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 1047000000.00
ACGL income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1047000000.00
ACGL income_statement (quarterly, 2026-03-31) — Net Interest Income: -37000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -626000000.00
ACGL income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -37000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -12000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -5000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -8000000.00
ACGL income_statement (quarterly, 2026-03-31) — Net Policyholder Benefits And Claims: 2089000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 22998000000.00
ACGL income_statement (quarterly, 2026-03-31) — Normalized Income: 1047000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 1188000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -46000000.00
ACGL income_statement (quarterly, 2026-03-31) — Operating Revenue: 4376000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 352900000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -333000000.00
ACGL income_statement (quarterly, 2026-03-31) — Other Income Expense: 54000000.00
ACGL income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 541000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 11261000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Payables: 4997000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 4997000000.00
ACGL income_statement (quarterly, 2026-03-31) — Policyholder Benefits Ceded: 742000000.00
ACGL income_statement (quarterly, 2026-03-31) — Policyholder Benefits Gross: 2831000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Preferred Shares Number: 830000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 830000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Preferred Stock Dividend Paid: -10000000.00
ACGL income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 10000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 830000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 3183000000.00
ACGL income_statement (quarterly, 2026-03-31) — Pretax Income: 1109000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -10009000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -8000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Receivables: 18511000000.00
ACGL income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 30000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -800000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 28082000000.00
ACGL cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 9383000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Share Issued: 602300000.00
ACGL cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 82000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 24188000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 22168000000.00
ACGL income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ACGL income_statement (quarterly, 2026-03-31) — Tax Provision: 98000000.00
ACGL income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.09
ACGL balance_sheet (quarterly, 2026-03-31) — Total Assets: 81446000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 26917000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Total Debt: 2729000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 24188000000.00
ACGL income_statement (quarterly, 2026-03-31) — Total Expenses: 3267000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 57258000000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 249400000.00
ACGL balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 7223000000.00
ACGLN cash_flow (annual, 2021-12-31) — Common Stock Issuance: 6000000.00
ACGLN balance_sheet (annual, 2021-12-31) — Current Debt: 0.00
ACGLN balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 0.00
ACGLN cash_flow (annual, 2021-12-31) — Financing Cash Flow: -1229000000.00
ACGLN income_statement (annual, 2021-12-31) — General And Administrative Expense: 78000000.00
ACGLN cash_flow (annual, 2021-12-31) — Issuance Of Debt: 0.00
ACGLN balance_sheet (annual, 2021-12-31) — Line Of Credit: 0.00
ACGLN cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
ACGLN cash_flow (annual, 2021-12-31) — Long Term Debt Payments: 0.00
ACGLN balance_sheet (annual, 2021-12-31) — Minority Interest: 9233000.00
ACGLN cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: 0.00
ACGLN cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 36000000.00
ACGLN income_statement (annual, 2021-12-31) — Other Gand A: 78000000.00
ACGLN income_statement (annual, 2021-12-31) — Otherunder Preferred Stock Dividend: 15000000.00
ACGLN cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 486000000.00
ACGLN cash_flow (annual, 2021-12-31) — Preferred Stock Payments: -450000000.00
ACGLN cash_flow (annual, 2021-12-31) — Purchase Of Business: -1103000000.00
ACGLN cash_flow (annual, 2021-12-31) — Repayment Of Debt: 0.00
ACGLN income_statement (annual, 2021-12-31) — Selling General And Administration: 78000000.00
ACGLN income_statement (annual, 2021-12-31) — Total Expenses: 6820000000.00
ACGLN income_statement (annual, 2022-12-31) — +Total Revenue: 9613000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Accounts Payable: 3264000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Accounts Receivable: 11920000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 2211000000.00
ACGLN income_statement (annual, 2022-12-31) — Amortization: 106000000.00
ACGLN cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 106000000.00
ACGLN cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 106000000.00
ACGLN cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1314000000.00
ACGLN cash_flow (annual, 2022-12-31) — Capital Expenditure: -50000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Capital Stock: 831000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 855000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 6500000000.00
ACGLN cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -40000000.00
ACGLN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -706000000.00
ACGLN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -3101000000.00
ACGLN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 3816000000.00
ACGLN cash_flow (annual, 2022-12-31) — Change In Account Payable: -36000000.00
ACGLN cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -434000000.00
ACGLN cash_flow (annual, 2022-12-31) — Change In Payable: -36000000.00
ACGLN cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -36000000.00
ACGLN cash_flow (annual, 2022-12-31) — Change In Receivables: -1110000000.00
ACGLN cash_flow (annual, 2022-12-31) — Change In Working Capital: 1335000000.00
ACGLN cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -1110000000.00
ACGLN cash_flow (annual, 2022-12-31) — Changes In Cash: 9000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Common Stock: 1000000.00
ACGLN cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: 0.00
ACGLN balance_sheet (annual, 2022-12-31) — Common Stock Equity: 12080000000.00
ACGLN cash_flow (annual, 2022-12-31) — Common Stock Issuance: 6000000.00
ACGLN cash_flow (annual, 2022-12-31) — Common Stock Payments: -586000000.00
ACGLN cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 106000000.00
ACGLN income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 106000000.00
ACGLN income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 1436000000.00
ACGLN income_statement (annual, 2022-12-31) — EBIT: 1618000000.00
ACGLN income_statement (annual, 2022-12-31) — Earnings From Equity Interest Net Of Tax: 75000000.00
ACGLN cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 154000000.00
ACGLN cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -50000000.00
ACGLN cash_flow (annual, 2022-12-31) — End Cash Position: 1273000000.00
ACGLN cash_flow (annual, 2022-12-31) — Financing Cash Flow: -706000000.00
ACGLN cash_flow (annual, 2022-12-31) — Free Cash Flow: 3766000000.00
ACGLN cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 651000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -1646000000.00
ACGLN income_statement (annual, 2022-12-31) — General And Administrative Expense: 95000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Goodwill: 342000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 804000000.00
ACGLN cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 255000000.00
ACGLN income_statement (annual, 2022-12-31) — Interest Expense: 131000000.00
ACGLN income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 131000000.00
ACGLN cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 128000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Invested Capital: 14805000000.00
ACGLN cash_flow (annual, 2022-12-31) — Investing Cash Flow: -3101000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Investments And Advances: 27215000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Investments In Other Ventures Under Equity Method: 4739000000.00
ACGLN cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 6000000.00
ACGLN cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
ACGLN balance_sheet (annual, 2022-12-31) — Long Term Debt: 2725000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 2725000000.00
ACGLN cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
ACGLN cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
ACGLN balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 4739000000.00
ACGLN income_statement (annual, 2022-12-31) — Loss Adjustment Expense: 5028000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Minority Interest: 11000000.00
ACGLN income_statement (annual, 2022-12-31) — Minority Interests: -6000000.00
ACGLN cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
ACGLN cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -580000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Net Debt: 1870000000.00
ACGLN income_statement (annual, 2022-12-31) — Net Income: 1476000000.00
ACGLN income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 1436000000.00
ACGLN income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 1482000000.00
ACGLN income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 1476000000.00
ACGLN income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 1476000000.00
ACGLN cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 1482000000.00
ACGLN income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 1482000000.00
ACGLN income_statement (annual, 2022-12-31) — Net Interest Income: -131000000.00
ACGLN cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -3176000000.00
ACGLN cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
ACGLN income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -131000000.00
ACGLN cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -86000000.00
ACGLN cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 125000000.00
ACGLN cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -50000000.00
ACGLN income_statement (annual, 2022-12-31) — Net Policyholder Benefits And Claims: 5028000000.00
ACGLN cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
ACGLN balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 12106000000.00
ACGLN income_statement (annual, 2022-12-31) — Normalized Income: 1476000000.00
ACGLN cash_flow (annual, 2022-12-31) — Operating Cash Flow: 3816000000.00
ACGLN cash_flow (annual, 2022-12-31) — Operating Gains Losses: 805000000.00
ACGLN income_statement (annual, 2022-12-31) — Operating Revenue: 9613000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 370345997.00
ACGLN balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -1646000000.00
ACGLN income_statement (annual, 2022-12-31) — Other Gand A: 95000000.00
ACGLN income_statement (annual, 2022-12-31) — Other Income Expense: -14000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 462000000.00
ACGLN income_statement (annual, 2022-12-31) — Other Operating Expenses: 1236000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 5645000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Payables: 3264000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 3264000000.00
ACGLN income_statement (annual, 2022-12-31) — Policyholder Benefits Ceded: 2521000000.00
ACGLN income_statement (annual, 2022-12-31) — Policyholder Benefits Gross: 7549000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 830000.00
ACGLN balance_sheet (annual, 2022-12-31) — Preferred Stock: 830000000.00
ACGLN cash_flow (annual, 2022-12-31) — Preferred Stock Dividend Paid: -40000000.00
ACGLN income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 40000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 830000000.00
ACGLN cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
ACGLN cash_flow (annual, 2022-12-31) — Preferred Stock Payments: 0.00
ACGLN balance_sheet (annual, 2022-12-31) — Prepaid Assets: 1799000000.00
ACGLN income_statement (annual, 2022-12-31) — Pretax Income: 1487000000.00
ACGLN cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
ACGLN cash_flow (annual, 2022-12-31) — Purchase Of Investment: -18976000000.00
ACGLN cash_flow (annual, 2022-12-31) — Purchase Of PPE: -50000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Receivables: 11920000000.00
ACGLN income_statement (annual, 2022-12-31) — Reconciled Depreciation: 106000000.00
ACGLN cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
ACGLN cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -586000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Retained Earnings: 15892000000.00
ACGLN cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
ACGLN cash_flow (annual, 2022-12-31) — Sale Of Investment: 15800000000.00
ACGLN income_statement (annual, 2022-12-31) — Selling General And Administration: 95000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Share Issued: 588250762.00
ACGLN cash_flow (annual, 2022-12-31) — Stock Based Compensation: 88000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Stockholders Equity: 12910000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Tangible Book Value: 11276000000.00
ACGLN income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
ACGLN income_statement (annual, 2022-12-31) — Tax Provision: 80000000.00
ACGLN income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.05
ACGLN balance_sheet (annual, 2022-12-31) — Total Assets: 47990000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Total Capitalization: 15635000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Total Debt: 2725000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 12921000000.00
ACGLN income_statement (annual, 2022-12-31) — Total Expenses: 8126000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 35069000000.00
ACGLN balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 217904765.00
ACGLN balance_sheet (annual, 2022-12-31) — Treasury Stock: 4378000000.00
ACGLN income_statement (annual, 2023-12-31) — +Total Revenue: 13297000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Accounts Payable: 3817000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Accounts Receivable: 13522000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 2327000000.00
ACGLN income_statement (annual, 2023-12-31) — Amortization: 95000000.00
ACGLN cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 95000000.00
ACGLN cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 95000000.00
ACGLN cash_flow (annual, 2023-12-31) — Beginning Cash Position: 1273000000.00
ACGLN cash_flow (annual, 2023-12-31) — Capital Expenditure: -52000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Capital Stock: 831000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 917000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 8047000000.00
ACGLN cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -40000000.00
ACGLN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -69000000.00
ACGLN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -5468000000.00
ACGLN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 5749000000.00
ACGLN cash_flow (annual, 2023-12-31) — Change In Account Payable: 455000000.00
ACGLN cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -1253000000.00
ACGLN cash_flow (annual, 2023-12-31) — Change In Payable: 455000000.00
ACGLN cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 455000000.00
ACGLN cash_flow (annual, 2023-12-31) — Change In Receivables: -981000000.00
ACGLN cash_flow (annual, 2023-12-31) — Change In Working Capital: 1152000000.00
ACGLN cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -981000000.00
ACGLN cash_flow (annual, 2023-12-31) — Changes In Cash: 212000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Common Stock: 1000000.00
ACGLN cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: 0.00
ACGLN balance_sheet (annual, 2023-12-31) — Common Stock Equity: 17523000000.00
ACGLN cash_flow (annual, 2023-12-31) — Common Stock Payments: -2000000.00
ACGLN cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 95000000.00
ACGLN income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 95000000.00
ACGLN income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 4403000000.00
ACGLN income_statement (annual, 2023-12-31) — EBIT: 3518000000.00
ACGLN income_statement (annual, 2023-12-31) — Earnings From Equity Interest Net Of Tax: 184000000.00
ACGLN cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: -215000000.00
ACGLN cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 13000000.00
ACGLN cash_flow (annual, 2023-12-31) — End Cash Position: 1498000000.00
ACGLN cash_flow (annual, 2023-12-31) — Financing Cash Flow: -69000000.00
ACGLN cash_flow (annual, 2023-12-31) — Free Cash Flow: 5697000000.00
ACGLN cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 182000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -676000000.00
ACGLN income_statement (annual, 2023-12-31) — General And Administrative Expense: 102000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Goodwill: 345000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 731000000.00
ACGLN cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 267000000.00
ACGLN income_statement (annual, 2023-12-31) — Interest Expense: 133000000.00
ACGLN income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 133000000.00
ACGLN cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 127000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Invested Capital: 20249000000.00
ACGLN cash_flow (annual, 2023-12-31) — Investing Cash Flow: -5468000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Investments And Advances: 33198000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Investments In Other Ventures Under Equity Method: 5685000000.00
ACGLN cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
ACGLN balance_sheet (annual, 2023-12-31) — Long Term Debt: 2726000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 2726000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 5685000000.00
ACGLN income_statement (annual, 2023-12-31) — Loss Adjustment Expense: 6246000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Minority Interest: 2000000.00
ACGLN income_statement (annual, 2023-12-31) — Minority Interests: 1000000.00
ACGLN cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
ACGLN cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -2000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Net Debt: 1809000000.00
ACGLN income_statement (annual, 2023-12-31) — Net Income: 4443000000.00
ACGLN income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 4403000000.00
ACGLN income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 4442000000.00
ACGLN income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 4443000000.00
ACGLN income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 4443000000.00
ACGLN cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 4442000000.00
ACGLN income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 4442000000.00
ACGLN income_statement (annual, 2023-12-31) — Net Interest Income: -133000000.00
ACGLN cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -5393000000.00
ACGLN income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -133000000.00
ACGLN cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -27000000.00
ACGLN cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -23000000.00
ACGLN cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -52000000.00
ACGLN income_statement (annual, 2023-12-31) — Net Policyholder Benefits And Claims: 6246000000.00
ACGLN cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
ACGLN balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 17622000000.00
ACGLN income_statement (annual, 2023-12-31) — Normalized Income: 4443000000.00
ACGLN cash_flow (annual, 2023-12-31) — Operating Cash Flow: 5749000000.00
ACGLN cash_flow (annual, 2023-12-31) — Operating Gains Losses: -33000000.00
ACGLN income_statement (annual, 2023-12-31) — Operating Revenue: 13297000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 373400000.00
ACGLN balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -676000000.00
ACGLN income_statement (annual, 2023-12-31) — Other Gand A: 102000000.00
ACGLN income_statement (annual, 2023-12-31) — Other Income Expense: 58000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 386000000.00
ACGLN income_statement (annual, 2023-12-31) — Other Operating Expenses: 1404000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 7130000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Payables: 3817000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 3817000000.00
ACGLN income_statement (annual, 2023-12-31) — Policyholder Benefits Ceded: 2468000000.00
ACGLN income_statement (annual, 2023-12-31) — Policyholder Benefits Gross: 8714000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Preferred Shares Number: 830000.00
ACGLN balance_sheet (annual, 2023-12-31) — Preferred Stock: 830000000.00
ACGLN cash_flow (annual, 2023-12-31) — Preferred Stock Dividend Paid: -40000000.00
ACGLN income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 40000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Preferred Stock Equity: 830000000.00
ACGLN cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
ACGLN cash_flow (annual, 2023-12-31) — Preferred Stock Payments: 0.00
ACGLN balance_sheet (annual, 2023-12-31) — Prepaid Assets: 2170000000.00
ACGLN income_statement (annual, 2023-12-31) — Pretax Income: 3385000000.00
ACGLN cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
ACGLN cash_flow (annual, 2023-12-31) — Purchase Of Investment: -21385000000.00
ACGLN cash_flow (annual, 2023-12-31) — Purchase Of PPE: -52000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Receivables: 13522000000.00
ACGLN income_statement (annual, 2023-12-31) — Reconciled Depreciation: 95000000.00
ACGLN cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -2000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Retained Earnings: 20295000000.00
ACGLN cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
ACGLN cash_flow (annual, 2023-12-31) — Sale Of Investment: 15992000000.00
ACGLN income_statement (annual, 2023-12-31) — Selling General And Administration: 102000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Share Issued: 591900000.00
ACGLN cash_flow (annual, 2023-12-31) — Stock Based Compensation: 93000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Stockholders Equity: 18353000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Tangible Book Value: 16792000000.00
ACGLN income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
ACGLN income_statement (annual, 2023-12-31) — Tax Provision: -873000000.00
ACGLN income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
ACGLN balance_sheet (annual, 2023-12-31) — Total Assets: 58906000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Total Capitalization: 21079000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Total Debt: 2726000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 18355000000.00
ACGLN income_statement (annual, 2023-12-31) — Total Expenses: 9912000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 40551000000.00
ACGLN balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 218500000.00
ACGLN balance_sheet (annual, 2023-12-31) — Treasury Stock: 4424000000.00
ACGLN balance_sheet (quarterly, 2024-09-30) — Minority Interest: 0.00
ACGLN income_statement (annual, 2024-12-31) — +Total Revenue: 16930000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Accounts Payable: 4302000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Accounts Receivable: 16055000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 2510000000.00
ACGLN income_statement (annual, 2024-12-31) — Amortization: 235000000.00
ACGLN cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 235000000.00
ACGLN cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 235000000.00
ACGLN cash_flow (annual, 2024-12-31) — Beginning Cash Position: 1498000000.00
ACGLN cash_flow (annual, 2024-12-31) — Capital Expenditure: -51000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Capital Stock: 831000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 979000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 9308000000.00
ACGLN cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -1906000000.00
ACGLN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -1925000000.00
ACGLN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -4461000000.00
ACGLN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 6673000000.00
ACGLN cash_flow (annual, 2024-12-31) — Change In Account Payable: 179000000.00
ACGLN cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -394000000.00
ACGLN cash_flow (annual, 2024-12-31) — Change In Payable: 179000000.00
ACGLN cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 179000000.00
ACGLN cash_flow (annual, 2024-12-31) — Change In Receivables: -818000000.00
ACGLN cash_flow (annual, 2024-12-31) — Change In Working Capital: 2666000000.00
ACGLN cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -818000000.00
ACGLN cash_flow (annual, 2024-12-31) — Changes In Cash: 287000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Common Stock: 1000000.00
ACGLN cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -1866000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Common Stock Equity: 19990000000.00
ACGLN cash_flow (annual, 2024-12-31) — Common Stock Issuance: 7000000.00
ACGLN cash_flow (annual, 2024-12-31) — Common Stock Payments: -24000000.00
ACGLN cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 235000000.00
ACGLN income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 235000000.00
ACGLN income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 4272000000.00
ACGLN income_statement (annual, 2024-12-31) — EBIT: 4615000000.00
ACGLN income_statement (annual, 2024-12-31) — Earnings From Equity Interest Net Of Tax: 200000000.00
ACGLN cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: -488000000.00
ACGLN cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -25000000.00
ACGLN cash_flow (annual, 2024-12-31) — End Cash Position: 1760000000.00
ACGLN cash_flow (annual, 2024-12-31) — Financing Cash Flow: -1925000000.00
ACGLN cash_flow (annual, 2024-12-31) — Free Cash Flow: 6622000000.00
ACGLN cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -185000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -720000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Goodwill: 571000000.00
ACGLN balance_sheet (quarterly, 2024-12-31) — Goodwill: 571000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 1351000000.00
ACGLN cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 378000000.00
ACGLN income_statement (annual, 2024-12-31) — Interest Expense: 141000000.00
ACGLN income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 141000000.00
ACGLN cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 127000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Invested Capital: 22718000000.00
ACGLN cash_flow (annual, 2024-12-31) — Investing Cash Flow: -4461000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Investments And Advances: 39645000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Investments In Other Ventures Under Equity Method: 7220000000.00
ACGLN cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 7000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Long Term Debt: 2728000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 2728000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 7220000000.00
ACGLN income_statement (annual, 2024-12-31) — Loss Adjustment Expense: 8342000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Minority Interest: 0.00
ACGLN balance_sheet (quarterly, 2024-12-31) — Minority Interest: 0.00
ACGLN income_statement (annual, 2024-12-31) — Minority Interests: 0.00
ACGLN cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 852000000.00
ACGLN cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
ACGLN cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -17000000.00
ACGLN balance_sheet (annual, 2024-12-31) — Net Debt: 1749000000.00
ACGLN income_statement (annual, 2024-12-31) — Net Income: 4312000000.00
ACGLN income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 4272000000.00
ACGLN income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 4312000000.00
ACGLN income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 4312000000.00
ACGLN income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 4312000000.00
ACGLN cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 4312000000.00
ACGLN income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 4312000000.00
ACGLN income_statement (annual, 2024-12-31) — Net Interest Income: -141000000.00
ACGLN cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -5232000000.00
ACGLN income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -141000000.00
ACGLN cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -2000000.00
ACGLN cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -30000000.00
ACGLN cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -51000000.00
ACGLN income_statement (annual, 2024-12-31) — Net Policyholder Benefits And Claims: 8342000000.00